KRAS and non-small cell lung carcinoma: Consistent with these findings, we have previously reported that EREG is a transcriptional target of oncogenic KRAS signaling in both KRAS-mutant NSCLC cells and bronchial epithelial cells expressing ectopic mutant KRAS [86].